Drug discovery conferences to keep on your radar in 2019

January 8, 2019 NanoTemper Technologies

Audience looking forward at a person on the conference stage, blue colored featured image

Update: See what 2020 drug discovery conferences you should watch for

With significant advancements in gene editing technologies, immuno-oncology, and artificial intelligence, 2018 was an exciting year for the drug discovery field.

To stay up to date on the latest developments, conferences are the place to be! But how do you choose with so many options out there? Don’t worry, we did the legwork for you and compiled a list of great conferences to go to in 2019.

 

PepTalk

January 14-18, San Diego, CA, USA

This is one of the largest gatherings of protein science researchers in the world. It attracts over 1,300 experts from academia, pharma and biotech who come together for one week of intensive learning and networking to discover new opportunities and promising partnerships. It covers a wide spectrum, from upstream protein R&D science to downstream biologics.

 

Festival of Biologics

March 3-5, San Diego, CA, USA

The Inaugural Festival of Biologics San Diego combines four outstanding conferences, focusing on antibodies, immunotherapies, clinical trials and biosimilars, all under one roof. It’ll bring together four high level, commercial events: The Americas Antibody Congress, the World Immunotherapy Congress USA, Clinical Trials America and the World Biosimilar Congress USA.

 

6th NovAlix Conference

March 20-11, Cannes, France

This “Biophysics in Drug Discovery” conference brings together biophysicists and medicinal chemists, a synergy that is key to deliver better drugs on a shorter timeline. This year the keynote lecture will be delivered by Professor Kurt Wüthrich, 2002 Nobel Prize in Chemistry winner. The conference will also cover hot topics including the complementarity between X-ray Crystallography and cryo-EM and characterization of small molecules binding to RNA.

 

14th Annual Drug Discovery Chemistry

April 8-12, San Diego, CA, USA

This meeting is a dynamic conference for medicinal chemists working in pharma and biotech. It focuses on the discovery and optimization challenges of small molecule drug candidates. New topics for this year’s conference include coverage of artificial intelligence for early drug discovery and directed evolution-based drug discovery. You can find even more in their interactive short courses.

 

17th Annual Discovery on Target

September 16-19, Boston, MA, USA

This meeting, which is organized by the Cambridge Healthtech Institute, brings forth current and emerging “hot” drug targets, technologies, and validation strategies for the development of novel small molecules and biologics. This year’s conference brings over 1,300 drug discovery professionals together to cover areas like diverse mechanisms of allosteric activation in DUB enzymes, development of CRISPR-based therapies, and targeting epigenetic readers.

 

10th Annual World Antibody-Drug Conjugate

October 9-11, San Diego, CA, USA

This conference covers every element of ADC drug development, from construct design to improving preclinical predictability and product manufacturability. You’ll hear from 100+ industry expert speakers who will give detailed presentations on: confidently predicting clinical toxicities preclinically, ADCs in combination with immuno-oncology agents, and discovering the application outside oncology.

 

Drug Discovery 2019

November 5-6, Liverpool, UK

The 13th Drug Discovery conference has become the largest meeting of life science industry professionals in the UK. This meeting brings together more than 1,200 delegates and over 100 exhibiting companies from around the world who highlight the latest ground-breaking research. You’ll also learn about cutting-edge advances in the application of laboratory technology to understand disease biology and to identify novel chemical and biological candidate drugs.

Previous Article
NanoTemper Technologies Brings Speed to Drug Discovery Screening, Launches Dianthus System
NanoTemper Technologies Brings Speed to Drug Discovery Screening, Launches Dianthus System

NanoTemper Technologies, maker of life science tools for protein characterization, launches its newest syst...

Up next
Improve the odds of your candidate becoming a drug
Improve the odds of your candidate becoming a drug

Around 90% of all biotherapeutic candidates fail during clinical development stages. If preclinical stages ...